Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death

On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a grea...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazim Mirza, Kathryn Landoski, Dilip Thakar, Jagtar Heir-Singh, Timothy Jackson, Cynthia Kassab
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Anesthesiology
Online Access:http://dx.doi.org/10.1155/2020/8767195
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547159557275648
author Kazim Mirza
Kathryn Landoski
Dilip Thakar
Jagtar Heir-Singh
Timothy Jackson
Cynthia Kassab
author_facet Kazim Mirza
Kathryn Landoski
Dilip Thakar
Jagtar Heir-Singh
Timothy Jackson
Cynthia Kassab
author_sort Kazim Mirza
collection DOAJ
description On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a great affinity for rocuronium and vecuronium. However, there have been several recently published case reports of bradycardia and asystole immediately after sugammadex administration for the reversal. This report presents a case of sugammadex administration followed by rapidly progressing bradycardia leading to asystole and subsequent death. The family has provided the written consent to share this case report.
format Article
id doaj-art-87c01c19340446d79ad1910fe8d61903
institution Kabale University
issn 2090-6382
2090-6390
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Anesthesiology
spelling doaj-art-87c01c19340446d79ad1910fe8d619032025-02-03T06:45:49ZengWileyCase Reports in Anesthesiology2090-63822090-63902020-01-01202010.1155/2020/87671958767195Sugammadex-Associated Hypotension, Bradycardia, Asystole, and DeathKazim Mirza0Kathryn Landoski1Dilip Thakar2Jagtar Heir-Singh3Timothy Jackson4Cynthia Kassab5MD Anderson Cancer Center, Houston, TX, USAMD Anderson Cancer Center, Houston, TX, USAMD Anderson Cancer Center, Houston, TX, USAMD Anderson Cancer Center, Houston, TX, USAMD Anderson Cancer Center, Houston, TX, USAMD Anderson Cancer Center, Houston, TX, USAOn December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a great affinity for rocuronium and vecuronium. However, there have been several recently published case reports of bradycardia and asystole immediately after sugammadex administration for the reversal. This report presents a case of sugammadex administration followed by rapidly progressing bradycardia leading to asystole and subsequent death. The family has provided the written consent to share this case report.http://dx.doi.org/10.1155/2020/8767195
spellingShingle Kazim Mirza
Kathryn Landoski
Dilip Thakar
Jagtar Heir-Singh
Timothy Jackson
Cynthia Kassab
Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
Case Reports in Anesthesiology
title Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
title_full Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
title_fullStr Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
title_full_unstemmed Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
title_short Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
title_sort sugammadex associated hypotension bradycardia asystole and death
url http://dx.doi.org/10.1155/2020/8767195
work_keys_str_mv AT kazimmirza sugammadexassociatedhypotensionbradycardiaasystoleanddeath
AT kathrynlandoski sugammadexassociatedhypotensionbradycardiaasystoleanddeath
AT dilipthakar sugammadexassociatedhypotensionbradycardiaasystoleanddeath
AT jagtarheirsingh sugammadexassociatedhypotensionbradycardiaasystoleanddeath
AT timothyjackson sugammadexassociatedhypotensionbradycardiaasystoleanddeath
AT cynthiakassab sugammadexassociatedhypotensionbradycardiaasystoleanddeath